AGRYLIN vs BESREMI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. AGRYLIN and BESREMI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AGRYLIN	BESREMI
Rating	New	New
Pharmacy pays	~$32.95 /30	—
Type	RX	RX
Active ingredient	ANAGRELIDE HYDROCHLORIDE	ROPEGINTERFERON ALFA-2B-NJFT
Manufacturer	Takeda Pharms USA	Pharmaessentia Corp
Dosage forms	Capsule	Injectable
Drug class	Platelet-Reducing Agent	—
Boxed warning	None	Boxed warning
Half-life	about 1.5 hours	—
Treats	Polycythemia Vera, Thrombocytosis	Polycythemia Vera

agrylin besremi

Rating

New

Pharmacy pays

~$32.95 /30

—

Type

Active ingredient

ANAGRELIDE HYDROCHLORIDE

ROPEGINTERFERON ALFA-2B-NJFT

Manufacturer

Takeda Pharms USA

Pharmaessentia Corp

Dosage forms

Capsule

Injectable

Drug class

Platelet-Reducing Agent

—

Boxed warning

None

Boxed warning

Half-life

about 1.5 hours

—

Treats

Polycythemia Vera, Thrombocytosis

Polycythemia Vera

Frequently asked questions

What is the difference between Agrylin and Besremi?

Agrylin contains Anagrelide Hydrochloride, while Besremi contains Ropeginterferon Alfa-2b-Njft — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.